Introduction of Metoprolol Increases Plasma B-Type Cardiac Natriuretic Peptides in Mild, Stable Heart Failure | Zendy

Mark Davis | Zendy; Mark Richards | Zendy; M. Gary Nicholls | Zendy; Timothy G. Yandle | Zendy; Christopher Frampton | Zendy; Richard W. Troughton | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Introduction of Metoprolol Increases Plasma B-Type Cardiac Natriuretic Peptides in Mild, Stable Heart Failure

Author(s) -

Mark Davis,

Mark Richards,

M. Gary Nicholls,

Timothy G. Yandle,

Christopher Frampton,

Richard W. Troughton

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.567727

Subject(s) - medicine , heart failure , metoprolol , natriuretic peptide , brain natriuretic peptide , cardiology , ejection fraction , atrial natriuretic peptide , blood pressure , endocrinology

The effect of beta-blockade on the cardiac natriuretic peptides is poorly understood but could contribute to their beneficial treatment effect and may be relevant to clinical use of plasma brain natriuretic peptide (BNP)/N-terminal pro brain natriuretic peptide (NTproBNP) measurements in risk stratification and in titration of anti-heart failure therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research